MEMBRANE
Online ISSN : 1884-6440
Print ISSN : 0385-1036
ISSN-L : 0385-1036
Volume 32, Issue 3
Displaying 1-8 of 8 articles from this issue
Special Issue : Erythrocyte Membrane : A potential Target of Basic,Clinical and Regenerative Medicine
Review Article
  • Sumie Manno, Yuichi Takakuwa
    2007Volume 32Issue 3 Pages 122-128
    Published: 2007
    Released on J-STAGE: June 18, 2015
    JOURNAL OPEN ACCESS
    Proteins are synthesized by translation of mRNA. Their functions are regulated by posttranslational modifications such as phosphorylation due to change in their structure as well as the physical and chemical properties. In this review article, we introduced in our experiences that phosphorylation and de-phosphorylation of erythrocyte membrane skeletal proteins such as spectrin and protein 4.1 (4.1R) change their interactions with binding partners with modification of membrane mechanical functions.
    Download PDF (746K)
  • Band 3 Protein as a Metabolic Sensor of Red Blood Cells
    Naotaka Hamasaki
    2007Volume 32Issue 3 Pages 129-138
    Published: 2007
    Released on J-STAGE: June 18, 2015
    JOURNAL OPEN ACCESS
    Oxygen is essential to most forms of life, but too much oxygen is harmful and can elicit tissue damage. Living creatures, therefore, have a tightly regulated system to deliver the necessary amount of oxygen to specific tissues at the right time. Red blood cells are ideal vehicles for delivering oxygen to tissues. Band 3 protein is the major membrane protein of red blood cells. The major membrane protein supports the oxygen delivering system by its anion exchange activity, cooperating with carbonic anhydrase and hemoglobin. Band 3 protein has unique structure within the molecule. Here, we briefly review the structure and function of band 3 protein.
    Download PDF (914K)
  • Phosphatidylserine on Red Cell Membrane as a Marker of Phagocytosis
    Hitoshi Kanno, Hisaichi Fujii
    2007Volume 32Issue 3 Pages 139-146
    Published: 2007
    Released on J-STAGE: June 18, 2015
    JOURNAL OPEN ACCESS
    The life span of human red blood cells (RBCs) is approximately for 120 days, and finally destroyed in reticuloendothelial systems. In pathological conditions, RBCs fall into premature death, i.e. hemolysis. Recent studies have unveiled that senescent RBCs as well as RBCs of hemolytic anemia subjects shared the common feature of exposure of phosphatidylserine (PS) in the outer leaflet of the RBC membrane. In addition, dying RBCs showed morphological and biochemical alterations resembling to apoptosis of nucleated cells such as cell shrinkage and protein degradation. In this review, mechanisms and physiological significance of PS externalization triggered by oxidative stress are discussed.
    Download PDF (761K)
  • Shoko Sato, Toshiro Nagasawa, Haruhiko Ninomiya
    2007Volume 32Issue 3 Pages 147-154
    Published: 2007
    Released on J-STAGE: June 18, 2015
    JOURNAL OPEN ACCESS
    Flow cytometry (FCM) is a useful tool to detect phenotypes of blood cells. Paroxysmal nocturnal hemoglobinuria (PNH), an acquired hematopoietic stem cell disorder, is characterized by its affected blood cells defective in the expression of glycosyl phosphatidylinositol (GPI)-anchored proteins. GPI-anchored membrane proteins on the red blood cells (RBC) include two major complement-regulatory membrane proteins, CD55 and CD59. The most characteristic clinical feature of PNH, intravascular hemolysis of PNH-affected RBC, is induced by the complement-mediated lysis of CD55- and CD59-negative PNH-RBC. In addition to the RBC membrane defects, leukocytes and platelets are also defective in the expression of GPI-anchored proteins, because of the PNH mutations occurred in the pluripotential hematopoietic stem cells. The GPI-anchored proteins with cell-lineage specificity, CD16b in neutrophils and CD14 in monocytes, are also shown to be deficient in PNH by FCM. We recently applied FCM to the demonstration of CD59-deficient populations in reticulocytes. FCM is also useful to demonstrate RBC membrane alteration in the aspects of lipids associated with the procoagulant pathophysiology in PNH.
    Download PDF (818K)
  • Kohichiro Tsuji
    2007Volume 32Issue 3 Pages 155-162
    Published: 2007
    Released on J-STAGE: June 18, 2015
    JOURNAL OPEN ACCESS
    Blood transfusion is an important therapy even at the developed present medicine. The main problems impeding progress in blood transfusion are the inconsistency of supply and the risk for infection of various microorganisms. Therefore, increased interest in the use of human stem cells has emerged following significant progress in ongoing stem cell biology research to procure a large quantity of safe blood for therapeutic transfusion. Although it is at present not possible to predict which types of stem cells will be best suitable for the efficient production of erythrocytes, the isolation of human embryonic stem cells and the discovery of adult stem cells (tissue stem cells) taken together give substance to hopes that novel principles may be developed in the procuration of blood cells for transfusion. To achieve this, however, we have to solve a number of technical and ethical problems.
    Download PDF (803K)
Review Article
Original Contribution
  • Shiho Asai, Kazuo Watanabe, Takanobu Sugo, Kyoichi Saito
    2007Volume 32Issue 3 Pages 168-174
    Published: 2007
    Released on J-STAGE: June 18, 2015
    JOURNAL OPEN ACCESS
    A basic extractant Aliquat 336 dissolved in a mixture of water and ethanol was impregnated to carboxypentyl-amino (CPA)-group-containing polymer chains grafted onto a porous hollow-fiber membrane. The CPA group was introduced into the graft chain by a reaction of the epoxy group of poly-glycidyl methacrylate (GMA) chain grafted onto the porous hollow-fiber membrane with 6-aminohexanoic acid. The electrostatic interaction between the carboxyl moiety of the CPA group and the quarternary ammonium group of Aliquat 336 gave rise to a high-density impregnation of Aliquat 336. A higher water volume fraction in the mixture of water and ethanol used as a solvent of Aliquat 336 induced a higher extension of the graft chain, resulting in an increase in the amount of Aliquat 336 impregnated. In addition, a higher Aliquat 336 concentration produced a higher amount of Aliquat 336 impregnated. A water volume fraction of 0.33 and an Aliquat 336 concentration of 10% were selected on the basis of a trade-off between the amount of Aliquat 336 impregnated and the liquid permeability. The pure water flux of porous hollow-fiber membrane with 1.2 mol Aliquat 336 per kg GMA-grafted porous hollow-fiber membrane was 2.5 m/h at 0.1 MPa and 298 K. During the permeation of 100 mg-Pt/L platinum chloride solution (pH 4.0) through the pores of the Aliquat 336- impregnated porous hollow-fiber membrane, platinum complex ions (PtCl6 2–) were captured by Aliquat 336 impregnated to the graft chain, while the permeation pressure required for a constant flow rate increased. The breakthrough binding capacity of the Aliquat 336-impregnated porous hollow-fiber membrane for platinum was 0.37 mol per kg of the GMA-grafted porous hollow-fiber membrane.
    Download PDF (671K)
Products Spotlight
  • Masaaki Ando
    2007Volume 32Issue 3 Pages 175-177
    Published: 2007
    Released on J-STAGE: June 18, 2015
    JOURNAL OPEN ACCESS
    The basic design concept of SWC5 launched this time consists with high permeability and high salt rejection. In general, high permeability and high salt rejection are in a trade-off relation. However, SWC5 successfully achieves high flow without sacrificing salt rejection significantly. This high flow makes it possible to operate at lower pressures than the conventional seawater RO when applying to seawater, to help operate better economics in seawater desalination as a result. SWC5 has already installed in several large scale seawater desalination plants and has been contributing to produce high quality low salinity water with lower operating cost.
    Download PDF (672K)
feedback
Top